The best indicator for GE HealthCare (GEHC)
We backtested 366 indicators across daily, weekly and hourly charts on real GE HealthCare (GEHC) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Laguerre RSI
On the daily chart, this is the strongest risk-adjusted edge we found for GE HealthCare (GEHC) over ~3.5 years — beating buy-and-hold by 15.2% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for GE HealthCare (GEHC) — beating buy-and-hold by 7.7% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Laguerre RSI ✓ | Daily | 17.5% | 1.09 | -16.0% | 64.0% | 25 | 15.2% |
| 2 | CMO (21) ✓ | Daily | 11.6% | 0.66 | -21.9% | 36.7% | 30 | 9.3% |
| 3 | Morning Star ✓ | Daily | 6.5% | 0.53 | -20.9% | 45.5% | 33 | 4.2% |
| 4 | ROC (20) | Daily | 8.7% | 0.52 | -24.7% | 41.2% | 34 | 6.3% |
| 5 | Momentum (20) | Daily | 8.7% | 0.52 | -24.7% | 41.2% | 34 | 6.3% |
| 6 | Bollinger Mean-Reversion ✓ | Daily | 8.6% | 0.55 | -23.6% | 71.4% | 14 | 6.2% |
| 7 | Fibonacci Bands ✓ | Daily | 8.6% | 0.55 | -23.6% | 71.4% | 14 | 6.2% |
| 8 | Chaikin Money Flow | Daily | 8.8% | 0.51 | -18.8% | 50.0% | 30 | 6.4% |
| 9 | Elder-Ray | Weekly | 5.1% | 0.58 | -7.5% | 61.5% | 13 | 1.1% |
| 10 | Ehlers Roofing Filter | Daily | 9.7% | 0.52 | -36.7% | 50.0% | 14 | 7.4% |
| 11 | Order-Flow Reversion ✓ | Daily | 7.8% | 0.51 | -22.6% | 76.9% | 13 | 5.4% |
| 12 | DeMarker (7) | Weekly | 7.4% | 0.47 | -16.8% | 46.2% | 13 | 3.5% |
| 13 | Connors RSI-2 | Daily | 5.8% | 0.39 | -27.3% | 61.4% | 44 | 3.5% |
| 14 | Stochastic RSI ✓ | Daily | 5.6% | 0.38 | -33.9% | 72.4% | 29 | 3.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For GE HealthCare (GEHC), Laguerre RSI on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.